- Stem cell research is growing twice as fast (7%) as the world average growth in research (2.9%). For the recent area of induced pluripotent stem cells (awarded the Nobel Prize in Physiology or Medicine in 2012), the annual growth rate since 2008 is an astonishing 77%.
- Stem cell publications are 50% more cited than the world average for all related subject areas, with the following field weighted citation impact (FWCI). ES cell publications maintained a citation impact of above 1.80 (2008-2012), while the hES cell citation impact declined marginally from 2.35 in 2008 to 2.08 in 2012. The emerging field of iPS cell research showed the highest impact within the stem cell field, with a FWCI of 2.93 (2008-2012).
- Around half of all stem cell papers use keywords related to "drug development" or "regenerative medicine" - Reflecting the field's ongoing development and clinical promise, 47% of stem cell publications used keywords related to regenerative medicine, while 2% used keywords related to drug development. However, iPS cell publications featured drug development more prominently (11% of iPS cell publications), and these papers were also associated with higher citation rates.
- While Singapore, Italy, the USA, Japan, and Israel show the highest level of activity in stem cell research, the US and China show the highest volume.
New Report On Stem Cell Research Reveals The Field Is Growing Twice As Fast As The World Average
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts